医学
围手术期
吉西他滨
奥沙利铂
内科学
性能状态
化疗
伊立替康
化疗方案
肿瘤科
临床试验
外科
腺癌
胰腺癌
叶黄素
癌症
结直肠癌
作者
Davendra Sohal,Mai Duong,Syed A. Ahmad,Namita Gandhi,Muhammad Shaalan Beg,Andrea Wang‐Gillam,James L. Wade,E. Gabriela Chiorean,Katherine A. Guthrie,Andrew M. Lowy,Philip A. Philip,Howard S. Höchster
出处
期刊:JAMA Oncology
[American Medical Association]
日期:2021-01-21
卷期号:7 (3): 421-421
被引量:230
标识
DOI:10.1001/jamaoncol.2020.7328
摘要
Clinical outcomes after curative treatment of resectable pancreatic ductal adenocarcinoma (PDA) remain suboptimal. To assess the potential of early control of systemic disease with multiagent perioperative chemotherapy, we conducted a prospective trial.
科研通智能强力驱动
Strongly Powered by AbleSci AI